A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma

NCT04718402 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped The sponsor has adjusted its R\&D strategy.

Conditions

Advanced Gastric Carcinoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome, intravenous injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.